Please activate JavaScript!
Please install Adobe Flash Player, click here for download
ePaper created 2016-06-09, 15:16:05 | version 1.38.0
Journal of Oral Science & Rehabilitation Volume 2 | Issue 2/2016 35 H u m a n i n d u c e d p l u r i p o t e n t s t e m c e l l s f r o m h u m a n o r a l m u c o s a 1. Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, Sridharan R, Clark AT, Plath K. Generation of human induced pluripotent stem cells from dermal fibroblasts. → Proc Natl Acad Sci U S A. 2008 Feb;105(8):2883–8. 2. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ. Reprogramming of human somatic cells to pluripotency with defined factors. → Nature. 2008 Jan;451(7175):141–6. 3. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. → Cell. 2007 Nov;131(5):861–72. 4. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. → Cell. 2006 Aug;126(4):663–76. 5. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. Induced pluripotent stem cell lines derived from human somatic cells. → Science. 2007 Dec;318(5858):1917–20. 6. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. → Nature. 1981 Jul;292(5819):154–6. 7. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. → Proc Natl Acad Sci U S A. 1981 Dec;78(12):7634–8. 8. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. → Science. 1998 Nov;282(5391):1145–7. 9. Su RJ, Neises A, Zhang XB. Generation of iPS cells from human peripheral blood mononuclear cells using episomal vectors. In: Turksen K, Nagy A, editors. Induced pluripotent stem (iPS) cells: methods and protocols. → New York: Springer; 2016. p. 57–69. (Walker JM, editor. Methods in molecular biology; vol. 1357). 10. Tamaoki N, Takahashi K, Tanaka T, Ichisaka T, Aoki H, Takeda-Kawaguchi T, Iida K, Kunisada T, Shibata T, Yamanaka S, Tezuka K. Dental pulp cells for induced pluripotent stem cell banking. → J Dent Res. 2010 Aug;89(8):773–8. 11. Egusa H, Okita K, Kayashima H, Yu G, Fukuyasu S, Saeki M, Matsumoto T, Yamanaka S, Yatani H. Gingival fibroblasts as a promising source of induced pluripotent stem cells. → PLoS One. 2010 Sep;5(9):e12743. 12. Wada N, Wang B, Lin NH, Laslett AL, Gronthos S, Bartold PM. Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts. → J Periodontal Res. 2011 Aug;46(4):438–47. 13. Miyoshi K, Tsuji D, Kudoh K, Satomura K, Muto T, Itoh K, Noma T. Generation of human induced pluripotent stem cells from oral mucosa. → J Biosci Bioeng. 2010 Sep;110(3):345–50. 14. Oda Y, Yoshimura Y, Ohnishi H, Tadokoro M, Katsube Y, Sasao M, Kubo Y, Hattori K, Saito S, Horimoto K, Yuba S, Ohgushi H. Induction of pluripotent stem cells from human third molar mesenchymal stromal cells. → J Biol Chem. 2010 Sep;285(38):29270–8. 15. Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, Hong H, Nakagawa M, Tanabe K, Tezuka K, Shibata T, Kunisada T, Takahashi M, Takahashi J, Saji H, Yamanaka S. A more efficient method to generate integration-free human iPS cells. → Nat Methods. 2011 May;8(5):409–12. 16. Su RJ, Baylink DJ, Neises A, Kiroyan JB, Meng X, Payne KJ, Tschudy-Seney B, Duan Y, Appleby N, Kearns-Jonker M, Gridley DS, Wang J, Lau KH, Zhang XB. Efficient generation of integration-free iPS cells from human adult peripheral blood using BCL-XL together with Yamanaka factors. → PLoS One. 2013 May;8(5):e64496. 17. Umezaki Y, Hashimoto Y, Nishishita N, Kawamata S, Baba S. Human gingival integration-free iPSCs; a source for MSC-like cells. → Int J Mol Sci. 2015 Jun;16(6):13633–48. 18. Maekawa M, Yamaguchi K, Nakamura T, Shibukawa R, Kodanaka I, Ichisaka T, Kawamura Y, Mochizuki H, Goshima N, Yamanaka S. Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. → Nature. 2011 Jun;474(7350):225–9. 19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. → Methods. 2001 Dec;25(4):402–8. 20. Gimbel M, Ashley RK, Sisodia M, Gabbay JS, Wasson KL, Heller J, Wilson L, Kawamoto HK, Bradley JP. Repair of alveolar cleft defects: reduced morbidity with bone marrow stem cells in a resorbable matrix. → J Craniofac Surg. 2007 Jul;18(4):895–901. 21. Sakamoto F, Hashimoto Y, Kishimoto N, Honda Y, Matsumoto N. The utility of human dedifferentiated fat cells in bone tissue engineering in vitro. → Cytotechnology. 2015 Jan;67(1):75–84. 22. Levi B, Glotzbach JP, Wong VW, Nelson ER, Hyun J, Wan DC, Gurtner GC, Longaker MT. Stem cells: update and impact on craniofacial surgery. → J Craniofac Surg. 2012 Jan;23(1):319–22. 23. Egusa H, Sonoyama W, Nishimura M, Atsuta I, Akiyama K. Stem cells in dentistry—part I: stem cell sources. → J Prosthodont Res. 2012 Jul;56(3):151–65. 24. Zhou W, Freed CR. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. → Stem Cells. 2009 Nov;27(11):2667–74. 25. Stephens P, Davies KJ, Occleston N, Pleass RD, Kon C, Daniels J, Khaw PT, Thomas DW. Skin and oral fibroblasts exhibit phenotypic differences in extracellular matrix reorganization and matrix metalloproteinase activity. → Br J Dermatol. 2001 Feb;144(2):229–37. 26. Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hämäläinen R, Cowling R, Wang W, Liu P, Gertsenstein M, Kaji K, Sung HK, Nagy A. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. → Nature. 2009 Apr;458(7239):766–70. 27. Jia F, Wilson KD, Sun N, Gupta DM, Huang M, Li Z, Panetta NJ, Chen ZY, Robbins RC, Kay MA, Longaker MT, Wu JC. A nonviral minicircle vector for deriving human iPS cells. → Nat Methods. 2010 Mar;7(3):197–9. 28. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. → Cell Stem Cell. 2010 Nov;7(5):618–30. 29. Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, Ko S, Yang E, Cha KY, Lanza R, Kim KS. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. → Cell Stem Cell. 2009 Jun;4(6):472–6. 30. Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. → Proc Jpn Acad Ser B Phys Biol Sci. 2009;85(8):348–62. 31. Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M, Okita K, Yamanaka S. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. → Nature. 2009 Aug;460(7259):1132–5. 32. Nakagawa M, Takizawa N, Narita M, Ichisaka T, Yamanaka S. Promotion of direct reprogramming by transformati- on-deficient Myc. → Proc Natl Acad Sci U S A. 2010 Aug;107(32):14152–7. 33. Shimada H, Hashimoto Y, Nakada A, Shigeno K, Nakamura T. Accelerated generation of human induced pluripotent stem cells with retroviral transduction and chemical inhibitors under physiological hypoxia. → Biochem Biophys Res Commun. 2012 Jan;417(2):659–64. References Volume 2 | Issue 2/201635